Sfoglia per Rivista CANCER
Mostrati risultati da 1 a 2 di 2
JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders. Cancer. 2006 Nov 1;107(9):2206-11. PubMed PMID: 16998940.
2006-01-01 Rumi, E; Passamonti, F; Pietra, D; Della Porta, M; Arcaini, L; Boggi, S; Elena, C; Boveri, E; Pascutto, C; Lazzarino, M; Cazzola, M
Treatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE-028 trial
2021-01-01 Reardon, David A; Kim, Tae Min; Frenel, Jean-Sebastien; Simonelli, Matteo; Lopez, Juanita; Subramaniam, Deepa S; Siu, Lillian L; Wang, Hui; Krishnan, Suba; Stein, Karen; Massard, Christophe
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| JAK2 (V617F) as an acquired somatic mutation and a secondary genetic event associated with disease progression in familial myeloproliferative disorders. Cancer. 2006 Nov 1;107(9):2206-11. PubMed PMID: 16998940. | 1-gen-2006 | Rumi, E; Passamonti, F; Pietra, D; Della Porta, M; Arcaini, L; Boggi, S; Elena, C; Boveri, E; Pascutto, C; Lazzarino, M; Cazzola, M | |
| Treatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE-028 trial | 1-gen-2021 | Reardon, David A; Kim, Tae Min; Frenel, Jean-Sebastien; Simonelli, Matteo; Lopez, Juanita; Subramaniam, Deepa S; Siu, Lillian L; Wang, Hui; Krishnan, Suba; Stein, Karen; Massard, Christophe |
Mostrati risultati da 1 a 2 di 2
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile